QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
Log in
NASDAQ:TRHC

Tabula Rasa HealthCare Stock Forecast, Price & News

$37.18
+2.68 (+7.77 %)
(As of 03/8/2021 12:00 AM ET)
Add
Compare
Today's Range
$34.50
Now: $37.18
$37.63
50-Day Range
$34.50
MA: $49.51
$62.72
52-Week Range
$30.12
Now: $37.18
$69.31
Volume1.58 million shs
Average Volume516,643 shs
Market Capitalization$917.68 million
P/E RatioN/A
Dividend YieldN/A
Beta1.05
Tabula Rasa HealthCare, Inc. provides patient-specific and data-driven technology and solutions in the field of medication safety in the United States. Its proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. The company offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems. Its cloud-based software also comprise RxCompanion, an MTM software platform designed to aid in the identification and resolution of medication and other health related problems; TruChart, an electronic health record (EHR) system for Programs of All-Inclusive Care for the Elderly (PACE) organizations; and PACElogic, which delivers real-time sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination, planning, integration with community-based providers, and various Federal and State required reporting. In addition, the company offers clinical pharmacist collaboration, prescription fulfillment and reminder packaging, and pharmacy cost management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2019, it served 237 healthcare organizations. The company provides its cloud-based software solutions to prescribers, pharmacists, pharmacies, and healthcare organizations for managing the medication-related needs of patients. It has collaboration with Innovative Integrated Health Community Plans, Inc.; and RxResults. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.
Tabula Rasa HealthCare logo

Headlines

See More Headlines

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TRHC
CUSIPN/A
Phone866-648-2767
Employees1,286
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$284.71 million
Cash Flow$1.29 per share
Book Value$8.36 per share

Profitability

Net Income$-32,440,000.00

Miscellaneous

Market Cap$917.68 million
Next Earnings Date5/6/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

1.46 out of 5 stars

Medical Sector

538th out of 1,971 stocks

Business Services, Not Elsewhere Classified Industry

59th out of 192 stocks

Analyst Opinion: 4.2Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
$37.18
+2.68 (+7.77 %)
(As of 03/8/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TRHC News and Ratings via Email

Sign-up to receive the latest news and ratings for TRHC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Tabula Rasa HealthCare (NASDAQ:TRHC) Frequently Asked Questions

Is Tabula Rasa HealthCare a buy right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Tabula Rasa HealthCare stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TRHC, but not buy additional shares or sell existing shares.
View analyst ratings for Tabula Rasa HealthCare
or view top-rated stocks.

What stocks does MarketBeat like better than Tabula Rasa HealthCare?

Wall Street analysts have given Tabula Rasa HealthCare a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Tabula Rasa HealthCare wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Tabula Rasa HealthCare's next earnings date?

Tabula Rasa HealthCare is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for Tabula Rasa HealthCare
.

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) released its quarterly earnings results on Wednesday, February, 24th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.10) by $0.02. Tabula Rasa HealthCare had a negative net margin of 19.48% and a negative trailing twelve-month return on equity of 11.53%.
View Tabula Rasa HealthCare's earnings history
.

How has Tabula Rasa HealthCare's stock been impacted by COVID-19?

Tabula Rasa HealthCare's stock was trading at $45.88 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TRHC stock has decreased by 19.0% and is now trading at $37.18.
View which stocks have been most impacted by COVID-19
.

What guidance has Tabula Rasa HealthCare issued on next quarter's earnings?

Tabula Rasa HealthCare updated its FY 2020 Pre-Market earnings guidance on Tuesday, January, 12th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $296-296 million, compared to the consensus revenue estimate of $294.76 million.

What price target have analysts set for TRHC?

9 brokers have issued 1-year price targets for Tabula Rasa HealthCare's stock. Their forecasts range from $40.00 to $72.00. On average, they expect Tabula Rasa HealthCare's share price to reach $52.20 in the next year. This suggests a possible upside of 40.4% from the stock's current price.
View analysts' price targets for Tabula Rasa HealthCare
or view top-rated stocks among Wall Street analysts.

Who are Tabula Rasa HealthCare's key executives?

Tabula Rasa HealthCare's management team includes the following people:
  • Dr. Calvin H. Knowlton, Co-Founder, Chairman & CEO (Age 71, Pay $616.28k)
  • Dr. Orsula Voltis Knowlton M.B.A., Pharm.D., BScPharm, PharmD, MBA, Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director (Age 52, Pay $470.08k)
  • Mr. Brian W. Adams, CFO & Sec. (Age 39, Pay $647.74k)
  • Mr. Michael Greenhalgh, Chief Operating Officer (Age 59)
  • Ms. Andrea Carolan Speers, Corp. Controller & Chief Accounting Officer (Age 39)
  • Mr. Bob Sullivan M.S., Chief Technology Officer
  • Mr. Joseph J. Filippoli, Chief Information Officer (Age 55)
  • Dr. Jacques Turgeon, Chief Scientific Officer (Age 61)
  • Mr. Phillip W. Heath MS, Chief Admin. Officer (Age 55)
  • Mr. Frank Sparacino C.F.A., CPA, CFA, CPA, Sr. VP of Investor Relations & Corp. Devel.

What is Calvin H. Knowlton, BScPharm, MDiv, PhD's approval rating as Tabula Rasa HealthCare's CEO?

24 employees have rated Tabula Rasa HealthCare CEO Calvin H. Knowlton, BScPharm, MDiv, PhD on Glassdoor.com. Calvin H. Knowlton, BScPharm, MDiv, PhD has an approval rating of 91% among Tabula Rasa HealthCare's employees. This puts Calvin H. Knowlton, BScPharm, MDiv, PhD in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Tabula Rasa HealthCare's key competitors?

What other stocks do shareholders of Tabula Rasa HealthCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), QUALCOMM (QCOM), Adobe (ADBE), Micron Technology (MU), (CGC), The Boeing (BA), salesforce.com (CRM), Intel (INTC) and Netflix (NFLX).

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an IPO on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Baird and Stifel were co-managers.

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

Who are Tabula Rasa HealthCare's major shareholders?

Tabula Rasa HealthCare's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (13.77%), Credit Suisse AG (6.05%), Artisan Partners Limited Partnership (5.35%), First Trust Advisors LP (4.95%), Bank of New York Mellon Corp (3.51%) and William Blair Investment Management LLC (3.11%). Company insiders that own Tabula Rasa HealthCare stock include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Michael Greenhalgh, Orsula V Knowlton and Samira Beckwith.
View institutional ownership trends for Tabula Rasa HealthCare
.

Which institutional investors are selling Tabula Rasa HealthCare stock?

TRHC stock was sold by a variety of institutional investors in the last quarter, including Emerald Advisers LLC, Price T Rowe Associates Inc. MD, Russell Investments Group Ltd., Emerald Mutual Fund Advisers Trust, Peregrine Capital Management LLC, Barclays PLC, RMB Capital Management LLC, and Summit Creek Advisors LLC. Company insiders that have sold Tabula Rasa HealthCare company stock in the last year include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Michael Greenhalgh, Orsula V Knowlton, and Samira Beckwith.
View insider buying and selling activity for Tabula Rasa HealthCare
or view top insider-selling stocks.

Which institutional investors are buying Tabula Rasa HealthCare stock?

TRHC stock was purchased by a variety of institutional investors in the last quarter, including First Trust Advisors LP, William Blair Investment Management LLC, BlackRock Inc., NN Investment Partners Holdings N.V., Tamarack Advisers LP, Baillie Gifford & Co., Millrace Asset Group Inc., and KBC Group NV.
View insider buying and selling activity for Tabula Rasa HealthCare
or or view top insider-buying stocks.

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tabula Rasa HealthCare's stock price today?

One share of TRHC stock can currently be purchased for approximately $37.18.

How much money does Tabula Rasa HealthCare make?

Tabula Rasa HealthCare has a market capitalization of $917.68 million and generates $284.71 million in revenue each year. The company earns $-32,440,000.00 in net income (profit) each year or ($0.25) on an earnings per share basis.

How many employees does Tabula Rasa HealthCare have?

Tabula Rasa HealthCare employs 1,286 workers across the globe.

What is Tabula Rasa HealthCare's official website?

The official website for Tabula Rasa HealthCare is www.tabularasahealthcare.com.

Where are Tabula Rasa HealthCare's headquarters?

Tabula Rasa HealthCare is headquartered at 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The company can be reached via phone at 866-648-2767 or via email at [email protected]


This page was last updated on 3/8/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.